课题基金 / 基金详情

Supplementation with Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) to Prevent Sarcopenia and Myosteatosis

Supplementation with Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) to Prevent Sarcopenia and Myosteatosis
补充二十碳五烯酸 (EPA) 和二十二碳六烯酸 (DHA) 可预防肌肉减少症和肌肉脂肪变性
批准号：
239577
负责人：
Mazurak Vera C
金额：
$31.96万
依托单位：
University of Alberta
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-09-01 至 2014-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=239577&lang=en
关键词：
Adipogenesis Essential Fatty Acids Lipid Metabolism Muscle Health Myosteatosis Nutrient Requirements Satellite Cells

项目摘要

项目成果

Mazurak Vera C的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal stems from our recent observations that muscle wasting is common in people with cancer. Often, muscle loss associates with increased content of fat in muscle. Each of these features is related to morbidity and survival in people with cancer
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Feeding EPA and DHA Improve Clinical Symptoms Associated with COVID-19 Infection
  • 批准号：
    442971
  • 项目类别：
    Operating Grants
  • 资助金额：
    $25.08万
  • 财政年份：
    2020
  • 负责人：
    Mazurak Vera C
  • 依托单位：
    University of Alberta
Dietary EPA and DHA Enhance Tumor Response and Protect against Muscle Loss and Myosteatosis During Chemotherapy Treatment
  • 批准号：
    403509
  • 项目类别：
    Operating Grants
  • 资助金额：
    $54.34万
  • 财政年份：
    2019
  • 负责人：
    Mazurak Vera C
  • 依托单位：
    University of Alberta
Factors that Regulate Eicosapentaenoic Acid and Docosahexaenoic Acid to Improve Cancer-Associated Myosteatosis
  • 批准号：
    322909
  • 项目类别：
    Operating Grants
  • 资助金额：
    $47.88万
  • 财政年份：
    2015
  • 负责人：
    Mazurak Vera C
  • 依托单位：
    University of Alberta
海外基金